KNOW Oncology’s Post

Cholangiocarcinoma Foundation's Chief Patient Officer Melinda Bachini co-authored "Amplifying the Patient's Voice in Oncology Early-Phase Clinical Trials: Solutions to Burdens and Barriers," which was recently published by American Society of Clinical Oncology (ASCO). Thank you to all the patients who participated in the spring survey that informed this publication—your insights drive meaningful change. When patients and caregivers participate in research, they make a difference by providing critical perspectives that can help shape the future of treatment options. Their participation ultimately expands clinical trials, which is essential for improving treatments and finding cures. The paper is available here: https://lnkd.in/gJXd9JGQ #ASCO #patientvoices #HopeInResearch #patientadvocacy #clinicaltrials

Attending #ASH2024? Be sure to check out our poster presentation on the "Evolution of Treatment Patterns and Survival Outcomes in European Patients with Multiple Myeloma (2012–2023) through the Honeur Federated Data Network" and discover how advancements like anti-CD38 therapies are improving survival outcomes for multiple myeloma patients. Learn more about our oncology experts and how they can help you https://ow.ly/Ew3650UlOjs

What an insightful few days for the Flatiron Health Germany team at #DGHO2024 - an incredibly important hematology and oncology conference in Germany! Our conversations with oncology clinics underscored a pressing challenge: care data is often underutilized and there is a huge need to unlock EHR data for research. In the German healthcare landscape, a variety of solutions and registries are emerging, each tailored to address specific challenges within oncology. These initiatives highlight the intricate nature of healthcare data and the critical need for collaboration. By embracing the idea that diverse Real-World Evidence (RWE) approaches can coexist and complement each other, we can harness the strengths of each system to improve patient care and enhance research outcomes. Let's improve #cancercare by learning from every patient's experience!

Looking for faster development of targeted oncology therapies for specific patient populations? 🤔We've got you covered! On October 9th, our expert Krishna Padmanabhan dives deeper into design considerations for adaptive population enrichment trials! 💡 Register here: https://hubs.ly/Q02R4tc80 hashtag#ClinicalTrials hashtag#OncologyTrials

We've got another staff member leading some insightful chats at SCRS Oncology next week! Join Business Development Manager, Brittany Irvin on April 10th at 3:00 PM for "Community Oncology Sites: Integrating Clinical Trials into Routine Patient Care." This will be an engaging panel discussion on how to integrate #clinicaltrials into community #oncology practice workflows and how to foster better collaboration. cc: Society for Clinical Research Sites (SCRS) #clinicalresearch #scrsoncology

At myDoctorAngel we are proud to announce a major milestone in our journey: integrating clinical research into our clinical practice! Our ambition is to develop an advanced platform to predict treatment responses and adverse drug events in oncology, harnessing the power of cutting-edge technology and innovation to improve patient outcomes. The protocol has officially been submitted to the ethics committee—fingers crossed for the next steps! This is just the beginning of an exciting new chapter for us, and we are eager to contribute to the future of personalized cancer care. Stay tuned for updates! #DigitalOncology #ClinicalResearch #InnovationInHealthcare #AIInOncology #MyDoctorAngel

Tremendous advances are made every day in the fight against cancer, but many promising treatments are costly, placing patients under enormous financial pressure that threatens their ability to achieve optimal outcomes.    In our recent case study, we examine the very real impact of high cost of care on cancer patients, how treatment in an independent practice can relieve financial burdens, and the benefits beyond cost that independent cancer centers provide.    Read it now:   #CostOfCare #CancerCare #CommunityOncology https://lnkd.in/gS3MGqh3

Have you considered all the most innovative trial designs for your oncology studies? 🤔 If you're aiming for faster development of targeted therapies for specific patient populations, adaptive population enrichment trials could be the answer. Join us on October 9th, where our expert Krishna P. will explore cutting-edge design considerations to optimize your oncology trials! 💡 Are you ready to unlock the potential of smarter trial designs? #Oncology #ClinicalTrials #Innovation #AdaptiveTrials

Looking for faster development of targeted oncology therapies for specific patient populations? 🤔We've got you covered! On October 9th, our expert Krishna Padmanabhan dives deeper into design considerations for adaptive population enrichment trials! 💡 Register here: https://hubs.ly/Q02PhYQp0 #ClinicalTrials #OncologyTrials

🚀 Digital Oncology is Much More than ePROs to Deliver Comprehensive Care Explore how healthcare providers can harness the power of AI, remote monitoring, and more to provide personalized, efficient, and comprehensive support for cancer patients. The exclusive roundtable discussion features expert insights from Andrew Norden, MD (OncoHealth) and Chet Robson, (Jasper Health). Register Now ➡️ https://lnkd.in/e7BkPiZ3 Key topics include: ✨ Integrating a diverse array of digital tools beyond just ePROs into oncology care pathways ✨ Addressing challenges and opportunities with widespread adoption of digital oncology solutions ✨ Enhancing interdisciplinary collaboration through seamless digital integration for improved patient outcomes Don't miss this chance to learn about the future of digital oncology! #DigitalHealth #OncologyCare #HLTH